You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Baxter
Johnson and Johnson
Mallinckrodt
Medtronic

Last Updated: September 28, 2020

DrugPatentWatch Database Preview

Patent: 4,405,047

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 4,405,047
Title: Unit package for poultry vaccination
Abstract:The invention provides a unit package for use in connection with a system for supplying liquid vaccine composition to an apparatus for substantially simultaneously debeaking and vaccinating poultry chicks. The package comprises a compartmentalized container the compartments of which contain (a) a plurality of liquid diluent supply bottles containing sterile diluent for rehydrating dehydrated vaccine, (b) a transfer spike assembly comprising a cover unit sealed with a tear-away cover and containing a transfer spike suitable for providing sterile flow means from a liquid diluent supply bottle to a bottle containing dehydrated vaccine and (c) a drip chamber-tubing-clamp assembly suitable for sterile transfer of liquid vaccine from a liquid supply bottle to the liquid injecting means of an apparatus for substantially simultaneously debeaking and vaccinating poultry chicks.
Inventor(s): Barba; Robert L. (Georgetown, DE)
Assignee: Sterling Drug, Inc. (New York, NY)
Application Number:06/285,318
Patent Claims:see list of patent claims

Details for Patent 4,405,047

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 001 2006-05-25   Start Trial Sterling Drug, Inc. (New York, NY) 2039-09-23 search
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 1 2006-05-25   Start Trial Sterling Drug, Inc. (New York, NY) 2039-09-23 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
McKinsey
Colorcon
Harvard Business School
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.